| RS2510077754 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510078765 |
ITGA2B
|
Health Risk |
Likely pathogenic |
ITGA2B-related disorder, ITGA2B-related disorder |
| RS2510078797 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510079259 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510079291 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510079502 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510079522 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510079586 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510079782 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510080068 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510080382 |
TANC2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autistic features and language delay, with or without seizures |
| RS2510080503 |
ITGA2B
|
Health Risk |
Likely pathogenic |
ITGA2B-related disorder, ITGA2B-related disorder |
| RS2510080622 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510082300 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510082644 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510082649 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510083090 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510083326 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510083991 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia 1, Glanzmann thrombasthenia 1 |
| RS2510084207 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510084269 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510084724 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510084868 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510084880 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510085106 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510085154 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510085199 |
SLC12A6
|
Health Risk |
Likely pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS2510085242 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia 1, Glanzmann thrombasthenia |
| RS2510085252 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2510085296 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2510085305 |
SLC12A6
|
Health Risk |
Likely pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Agenesis of the corpus callosum with peripheral neuropathy |
| RS2510085323 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510085373 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510085513 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510085546 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510085780 |
LAMA1
|
Health Risk |
Likely pathogenic |
— |
| RS2510086646 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2510086719 |
SLC12A6
|
Health Risk |
Pathogenic |
— |
| RS2510087925 |
TBCD
|
Health Risk |
Likely pathogenic |
— |
| RS2510087960 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510088074 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510088109 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS2510088557 |
TBCD
|
Health Risk |
Pathogenic |
— |
| RS2510088678 |
TBCD
|
Health Risk |
Pathogenic |
— |
| RS2510089206 |
LAMA1
|
Health Risk |
Pathogenic |
LAMA1-related disorder, LAMA1-related disorder |
| RS2510091792 |
LAMA1
|
Health Risk |
Pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2510096294 |
LAMA1
|
Health Risk |
Pathogenic |
— |
| RS2510097246 |
SMCHD1
|
Health Risk |
Likely pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510098307 |
TANC2
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with autistic features and language delay, with or without seizures |
| RS2510102579 |
BPTF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies |
| RS2510103152 |
SMCHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2510109572 |
LAMA1
|
Health Risk |
Pathogenic |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome, Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome |
| RS2510110238 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510110251 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510118137 |
PYCR1
|
Health Risk |
Pathogenic |
— |
| RS2510120701 |
PYCR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cutis laxa, Cutis laxa |
| RS2510120727 |
PYCR1
|
Health Risk |
Pathogenic |
Cutis laxa, Cutis laxa |
| RS2510122804 |
SMCHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2510150838 |
SMCHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2510151392 |
NDUFV2
|
Health Risk |
Likely pathogenic |
— |
| RS2510152204 |
SMCHD1
|
Health Risk |
Likely pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510152222 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2510155571 |
NDUFV2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2510155602 |
NDUFV2
|
Health Risk |
Pathogenic |
— |
| RS2510156483 |
SMCHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2510180471 |
SMCHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2510196039 |
RAC3
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies, Neurodevelopmental disorder with structural brain anomalies and dysmorphic facies |
| RS2510205603 |
TANC2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autistic features and language delay, with or without seizures |
| RS2510211807 |
MTCL1
|
Health Risk |
Pathogenic |
Cerebellar ataxia, Cerebellar ataxia |
| RS2510213796 |
TUBB6
|
Health Risk |
Likely pathogenic |
Ptosis, Ptosis |
| RS2510220484 |
AFG3L2
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 28, Spinocerebellar ataxia type 28 |
| RS2510220593 |
AFG3L2
|
Health Risk |
Pathogenic |
— |
| RS2510223754 |
AFG3L2
|
Health Risk |
Likely pathogenic |
Spastic ataxia 5, Spastic ataxia 5 |
| RS2510225840 |
PIGW
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 5, Hyperphosphatasia with intellectual disability syndrome 5 |
| RS2510226231 |
PIGW
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 5, Hyperphosphatasia with intellectual disability syndrome 5 |
| RS2510230443 |
AFG3L2
|
Health Risk |
Pathogenic |
— |
| RS2510233343 |
AFG3L2
|
Health Risk |
Pathogenic |
— |
| RS2510234186 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Marden-Walker syndrome, Marden-Walker syndrome |
| RS2510238432 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS2510238970 |
ATP6V0A1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 104, Developmental and epileptic encephalopathy 104 |
| RS2510244017 |
ATP6V0A1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with epilepsy and brain atrophy, Neurodevelopmental disorder with epilepsy and brain atrophy |
| RS2510246095 |
LPIN2
|
Health Risk |
Likely pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2510249341 |
LPIN2
|
Health Risk |
Pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2510249351 |
LPIN2
|
Health Risk |
Pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2510253000 |
TBCD
|
Health Risk |
Pathogenic |
— |
| RS2510256104 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS2510257285 |
PIEZO2
|
Health Risk |
Likely pathogenic |
PIEZO2-related disorder, PIEZO2-related disorder |
| RS2510259475 |
GNAL
|
Health Risk |
Pathogenic |
Dystonic disorder, Dystonic disorder |
| RS2510260408 |
GNAL
|
Health Risk |
Likely pathogenic |
— |
| RS2510266165 |
LPIN2
|
Health Risk |
Likely pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2510266170 |
LPIN2
|
Health Risk |
Likely pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2510267437 |
LPIN2
|
Health Risk |
Pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2510271888 |
ATP6V0A1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 104, Developmental and epileptic encephalopathy 104 |
| RS2510272028 |
PIEZO2
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS2510280879 |
PIEZO2
|
Health Risk |
Likely pathogenic |
PIEZO2-related disorder, PIEZO2-related disorder |
| RS2510282875 |
LPIN2
|
Health Risk |
Pathogenic |
Majeed syndrome, Majeed syndrome |
| RS2510283811 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2510284153 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2510284231 |
TANC2
|
Health Risk |
Pathogenic |
— |
| RS2510284280 |
CCDC40
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |